Covered recipient · General Payments record
KUMARAVELU BALASUBRAMANIAM
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2019–2025
$3,305.89
- Reported across 95 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $334.35 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $240.60 | 14 |
| GENZYME CORPORATION | $28.66 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $24.79 | 1 |
| Novo Nordisk AS | $20.44 | 1 |
| Janssen Biotech, Inc. | $19.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.21 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463587 | CMS |
| ABBVIE INC. | $23.77 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463589 | CMS |
| ABBVIE INC. | $17.31 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463591 | CMS |
| ABBVIE INC. | $11.31 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463593 | CMS |
| ABBVIE INC. | $17.34 | 05/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463595 | CMS |
| ABBVIE INC. | $15.01 | 06/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463597 | CMS |
| ABBVIE INC. | $10.00 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463599 | CMS |
| ABBVIE INC. | $15.00 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463601 | CMS |
| ABBVIE INC. | $20.14 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463603 | CMS |
| ABBVIE INC. | $6.87 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463605 | CMS |
| ABBVIE INC. | $17.09 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463607 | CMS |
| ABBVIE INC. | $33.11 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463609 | CMS |
| ABBVIE INC. | $33.52 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463611 | CMS |
| ABBVIE INC. | $12.92 | 12/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201463613 | CMS |
| Boston Scientific Corporation | $24.79 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181172346 | CMS |
| GENZYME CORPORATION | $28.66 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233376378 | CMS |
| Janssen Biotech, Inc. | $19.86 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174758903 | CMS |
| Novo Nordisk Inc | $20.44 | 10/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188821209 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.